Mesoblast (ASX:MSB) said it drew down $50 million from a five-year facility provided by Gregory George, a shareholder and director of the company, according to a Thursday filing with the Australian bourse.
The credit line carries a fixed interest rate of 8% per year, which marks "a substantial reduction" from prior facilities, the company said.
Mesoblast had $122 million of cash at the end of March and "is well funded to invest in its commercial operations and growth pipeline," it said.
The company's shares fell nearly 2% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments